These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30360704)

  • 1. Bacterial Lipoprotein Biosynthetic Pathway as a Potential Target for Structure-based Design of Antibacterial Agents.
    Xia J; Feng B; Wen G; Xue W; Ma G; Zhang H; Wu S
    Curr Med Chem; 2020; 27(7):1132-1150. PubMed ID: 30360704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Escherichia coli Lipoprotein Diacylglyceryl Transferase Is Insensitive to Resistance Caused by Deletion of Braun's Lipoprotein.
    Diao J; Komura R; Sano T; Pantua H; Storek KM; Inaba H; Ogawa H; Noland CL; Peng Y; Gloor SL; Yan D; Kang J; Katakam AK; Volny M; Liu P; Nickerson NN; Sandoval W; Austin CD; Murray J; Rutherford ST; Reichelt M; Xu Y; Xu M; Yanagida H; Nishikawa J; Reid PC; Cunningham CN; Kapadia SB
    J Bacteriol; 2021 Jun; 203(13):e0014921. PubMed ID: 33875545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Lipoprotein Biogenesis: Considerations towards Antimicrobials.
    El Arnaout T; Soulimane T
    Trends Biochem Sci; 2019 Aug; 44(8):701-715. PubMed ID: 31036406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Design of Cyclic Peptide Inhibitors of a Bacterial Membrane Lipoprotein Peptidase.
    Craven TW; Nolan MD; Bailey J; Olatunji S; Bann SJ; Bowen K; Ostrovitsa N; Da Costa TM; Ballantine RD; Weichert D; Levine PM; Stewart LJ; Bhardwaj G; Geoghegan JA; Cochrane SA; Scanlan EM; Caffrey M; Baker D
    ACS Chem Biol; 2024 May; 19(5):1125-1130. PubMed ID: 38712757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative Treatment of Severe Gram-Negative Bacterial Infections by a New Class of Antibiotics Targeting LpxC.
    Lemaître N; Liang X; Najeeb J; Lee CJ; Titecat M; Leteurtre E; Simonet M; Toone EJ; Zhou P; Sebbane F
    mBio; 2017 Jul; 8(4):. PubMed ID: 28743813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into lipoprotein N-acylation by
    Noland CL; Kattke MD; Diao J; Gloor SL; Pantua H; Reichelt M; Katakam AK; Yan D; Kang J; Zilberleyb I; Xu M; Kapadia SB; Murray JM
    Proc Natl Acad Sci U S A; 2017 Jul; 114(30):E6044-E6053. PubMed ID: 28698362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The folic acid biosynthesis pathway in bacteria: evaluation of potential for antibacterial drug discovery.
    Bermingham A; Derrick JP
    Bioessays; 2002 Jul; 24(7):637-48. PubMed ID: 12111724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The targets of currently used antibacterial agents: lessons for drug discovery.
    Lange RP; Locher HH; Wyss PC; Then RL
    Curr Pharm Des; 2007; 13(30):3140-54. PubMed ID: 17979755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phylum level analysis reveals lipoprotein biosynthesis to be a fundamental property of bacteria.
    Sutcliffe IC; Harrington DJ; Hutchings MI
    Protein Cell; 2012 Mar; 3(3):163-70. PubMed ID: 22410786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships of the MEPicides: N-Acyl and O-Linked Analogs of FR900098 as Inhibitors of Dxr from Mycobacterium tuberculosis and Yersinia pestis.
    San Jose G; Jackson ER; Haymond A; Johny C; Edwards RL; Wang X; Brothers RC; Edelstein EK; Odom AR; Boshoff HI; Couch RD; Dowd CS
    ACS Infect Dis; 2016 Dec; 2(12):923-935. PubMed ID: 27676224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of lipoprotein signal peptidase II action and inhibition by the antibiotic globomycin.
    Vogeley L; El Arnaout T; Bailey J; Stansfeld PJ; Boland C; Caffrey M
    Science; 2016 Feb; 351(6275):876-80. PubMed ID: 26912896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The coordinated action of the enzymes in the L-lysine biosynthetic pathway and how to inhibit it for antibiotic targets.
    Muduli S; Karmakar S; Mishra S
    Biochim Biophys Acta Gen Subj; 2023 May; 1867(5):130320. PubMed ID: 36813209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformational dynamics of the membrane enzyme LspA upon antibiotic and substrate binding.
    Caldwell TA; Vickery ON; Colburn JD; Stansfeld PJ; Columbus L
    Biophys J; 2022 Jun; 121(11):2078-2083. PubMed ID: 35505611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mode of action of lipoprotein modification enzymes-Novel antibacterial targets.
    Legood S; Boneca IG; Buddelmeijer N
    Mol Microbiol; 2021 Mar; 115(3):356-365. PubMed ID: 32979868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stringency of bacterial prolipoprotein signal peptidase (LspA) in recognition of signal peptides - Structure-function correlation.
    Sangith N; Sankaran K
    Biochem Biophys Res Commun; 2017 Jun; 488(2):413-417. PubMed ID: 28506828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate biosynthesis pathway: mechanisms and insights into drug design for infectious diseases.
    Bertacine Dias MV; Santos JC; Libreros-Zúñiga GA; Ribeiro JA; Chavez-Pacheco SM
    Future Med Chem; 2018 Apr; 10(8):935-959. PubMed ID: 29629843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.